Akebia Therapeutics, Inc. (AKBA) Free Cash Flow
Akebia Therapeutics, Inc. (AKBA) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | $55.24M |
| 2017-12-31 | -$57.78M |
| 2018-12-31 | -$99.10M |
| 2019-12-31 | -$264.11M |
| 2020-12-31 | -$110.68M |
| 2021-12-31 | -$253.04M |
| 2022-12-31 | -$73.27M |
| 2023-12-31 | -$23.38M |
| 2024-12-31 | -$40.69M |
| 2025-12-31 | $67.70M |
How AKBA compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| AZTA | Azenta Inc. | $38.32M |
| NRC | National Research Corporation | $15.74M |
| ETON | Eton Pharmaceuticals Inc. | $10.19M |
| TXMD | TherapeuticsMD Inc. | $2.45M |
| CERS | Cerus Corporation | $1.11M |
These are five companies in the same sector as AKBA with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Akebia Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("AKBA", 2025, "")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | AKBA | $0.80 | -1.68% | 6.09M |
| 3 | ||||
| 4 | ||||
| 5 |